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Background: 
The heat shock response (HSR) is a stress 
response pathway to counteract proteotoxic 
effects of aberrantly folded proteins. 
Results: 
The HSR is deregulated by PrPSc and Aβ and 
can protect against toxic effects of PrPSc, Aβ and 
a neurotoxic PrP mutant. 
Conclusions: 
The toxicity of different pathogenic proteins is 
mediated via similar cellular pathways. 
Significance: 
Identifying cellular pathways activated by 
neurotoxic proteins will help to develop 
therapeutic strategies. 
 
SUMMARY 
 The heat shock response (HSR) is an 
evolutionarily conserved pathway designed to 
maintain proteostasis and to ameliorate toxic 
effects of aberrant protein folding. We have 
studied the modulation of the HSR by the 
scrapie prion protein (PrPSc) and amyloid 
beta peptide (Aβ) and investigated whether 
an activated HSR or the ectopic expression of 
individual chaperones can interfere with 
PrPSc- or Aβ-induced toxicity. First, we 
observed different effects on the HSR under 
acute or chronic exposure of cells to PrPSc or 
Aβ . In chronically exposed cells the threshold 
to mount a stress response was significantly 
increased, evidenced by a decreased 
expression of Hsp72 after stress, while an 
acute exposure lowered the threshold for 
stress-induced expression of Hsp72. Next, we 
employed models of PrPSc- and Aβ-induced 
toxicity to demonstrate that the induction of 
the HSR ameliorates the toxic effects of both 
PrPSc and Aβ . Similarly, the ectopic 
expression of cytosolic Hsp72 or the 
extracellular chaperone clusterin protected 
against PrPSc- or Aβ-induced toxicity. 
However, toxic signaling induced by a 
pathogenic PrP mutant located at the plasma 
membrane was prevented by an activated 
HSR or Hsp72 but not by clusterin, indicating 
a distinct mode of action of this extracellular 
chaperone. Our study supports the notion 
that different pathological protein conformers 
mediate toxic effects via similar cellular 
pathways and emphasizes the possibility to 
exploit the heat shock response 
therapeutically. 
 Accumulation of misfolded and 
aggregated proteins is a hallmark of various 
neurodegenerative diseases. Prion diseases (rev. 
in (1-4)) and Alzheimer's disease (AD) (rev. in 
(5,6)) are characterized by extracellular protein 
assemblies formed by the scrapie prion protein 
(PrPSc) or amyloid beta (Aβ) peptide, 
respectively. Whereas prion diseases and AD are 
clearly distinct disease entities, there appear to 
be commonalities concerning structural features 
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of the pathogenic protein conformers as well as 
pathways implicated in their toxic effects (rev. in 
(7-10)). 
 The protein deposits found in AD or 
prion diseases are associated with intra- and 
extracellular heat shock proteins (Hsps) (11-13), 
suggesting a role of Hsps in the pathogenic 
process. Hsps, many of which function as 
molecular chaperones, comprise a class of 
proteins that are induced under conditions of 
cellular stress when the concentration of 
aggregation-prone folding intermediates are 
increasing. However, Hsps exert fundamental 
functions also under physiological conditions 
since they are vitally engaged in protein folding, 
trafficking and regulation of signaling pathways 
(rev. in (14)). Hsps are found in all cellular 
compartments and organelles. In addition, 
clusterin is a secreted chaperone shown to be 
involved in the extracellular protein quality 
control system (15). Upregulation of Hsps after 
acute or chronic proteotoxic damage is mediated 
by a highly conserved pathway denoted the heat 
shock response (HSR). At the molecular level, 
different stressors are integrated through the 
activation of a single transcription factor, the 
heat shock transcription factor 1 (HSF1), which 
binds to specific heat shock element (HSE) 
sequences present in the promoter region of 
inducible Hsp genes (rev. in (16,17)). An 
increase in Hsp levels prevents protein 
aggregation and facilitates correct folding of 
non-native proteins after cellular stress. In 
addition, chaperones participate in anti-apoptotic 
pathways (rev. in (18-20)). It is therefore not 
surprising that a deregulation of the HSR can 
contribute to the progression of various diseases. 
Consequently, the HSR represents a target for 
therapeutic intervention in a range of  diseases 
(rev. in (21-26)). For example, pharmacological 
induction of the HSR was shown to ameliorate 
disease progression and neuropathological 
alterations in mouse models of 
neurodegenerative diseases (27-29). Supporting 
a protective role of the HSR, deletion of HSF1 
dramatically shortened the lifespan of scrapie-
infected mice (30). 
 We have previously studied the HSR in 
scrapie-infected mouse neuroblastoma (ScN2a) 
cells, which offer a useful model to study certain 
aspects of prion diseases in cultured cells. Most 
importantly, ScN2a cells propagate partially 
protease-resistant PrPSc and infectious prions 
(31,32). The stress-induced expression of Hsp72 
and Hsp28 is significantly impaired in ScN2a 
cells, whereas their uninfected counterparts are 
able to mount a normal stress response (33,34). 
Notably, we found that the impaired HSR in 
ScN2a cells is caused by an accelerated 
deactivation of HSF1 after stress and can be 
restored by the Hsp90-binding drug 
geldanamycin (34).  
 In this study, we characterized the 
impact of pathogenic protein conformers on the 
regulation of HSR by making use of cell culture 
models of PrPSc- and Aβ-induced toxicity. We 
demonstrate that PrPSc and Aβ have different 
effects on the HSR depending on whether they 
are applied in an acute or chronic manner to 
cells. Moreover, activation of the HSR or 
ectopic expression of individual chaperons is 
protective against PrPSc- and Aβ-induced cell 
death as well as the toxic activity of a 
pathogenic PrP mutant. 
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EXPERIMENTAL PROCEDURES 
Plasmids, antibodies and reagents 
Expression constructs have been described 
previously: PrPC (35); HSE-luc (36); Hsp72 
(37); ΔHSF, wtHSF (38); PrPΔHD (35); 
pRc/VMV-clusterin (39). Amino acid numbers 
refer to mouse prion protein sequence 
(GenBankTM accession number NP 035300). As 
transfection marker the EYFP-C1 vector 
(Clontech) was used. The following antibodies 
were used: mouse monoclonal anti-PrP 3F4 
antibody (40), rabbit polyclonal anti-PrP 
antibody A7 (41), mouse monoclonal anti-Hsp72 
antibody C92 (42), mouse monoclonal anti-
clusterin antibody 41D (43), mouse monoclonal 
anti-β-actin antibody (Sigma), rabbit polyclonal 
anti-active caspase-3 antibody (Promega), 
fluorescent dye-labeled anti-rabbit IgG antibody 
Alexa Fluor® 555 (Invitrogen), fluorescent dye-
labeled anti-mouse IgG antibody Alexa Flour® 
555 (Invitrogen), horseradish peroxidase-
conjugated anti-mouse IgG antibody 
(Amersham, Promega), horseradish peroxidase-
conjugated anti-rabbit IgG antibody (Promega), 
horseradish peroxidase-conjugated anti-rat IgG 
antibody (Santa Cruz Biotechnology), rat 
monoclonal anti-Aβ antibody 2D8 (44), rabbit 
polyclonal anti-Aβ antibody 3552 (45). The 
following reagents were used: TO-PRO®-3 
iodide (642/661) (Invitrogen), DAPT (N-[N-
(3,5-difluorophenacetyl)-L-alanyl]-S-
phenylglycine t-butyl ester). The mounting 
medium Mowiol (Calbiochem) was 
supplemented with DAPI (4´,6-diamidino-2-
phenylindole; Sigma-Aldrich).  
Cell culture, transfection, co-culture  
Cells were cultured and transfected as described 
earlier (35). The human SH-SY5Y cell line 
(DSMZ number ACC 209) is a sub-line of bone 
marrow biopsy-derived SK-N-SH cells. Stably 
transfected Chinese hamster ovary cells (CHO-
7PA2) that express the familial AD mutation 
V717F in the amyloid precursor protein APP751 
and secrete Aβ were described earlier (46). Cells 
cultured in 3.5 cm dishes were transfected with 
DNA by a liposome-mediated method using 
LipofectAMIN Plus reagent (Invitrogen) 
according to the manufacturer´s instructions. For 
co-culture experiments, SH-SY5Y cells were 
grown on glass coverslips. 2 h after transfection 
coverslips were transferred into dishes 
containing a 90% confluent cell layer of either 
ScN2a or N2a or CHO-7PA2 or CHO cells 
(47,48). After 16 h or 24 h of co-culture, either 
apoptotic cell death or luciferase activity was 
analyzed (see below). For stable transfection, 
SH-SY5Y cells were transfected with the 
plasmid pCEP4 containing the coding sequence 
for APP695 using Transfectine (Bio-Rad) 
according to the manufacturer´s instructions. 
Stably transfected cells were selected with 
hygromycin (250 µg/ml). The empty vector was 
used as control (mock-transfected).  
Cell lysis, immunoprecipitation and Western blot 
analysis 
As described earlier (49), cells were washed 
twice with cold phosphate-buffered saline 
[PBS], scraped off the plate and lysed in cold 
detergent buffer A (0.5% Triton X-100, 0.5% 
sodium deoxycholate in PBS). Total lysates or 
secreted and trichloroacetic acid (TCA)-
precipitated proteins were boiled with Laemmli 
sample buffer and analyzed by Western blotting 
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as described previously (50). For proteolysis 
experiments, lysates of ScN2a or N2a cells were 
digested with Proteinase K for 30 min at 37°C 
(final concentration 10 µg/ml). Reaction was 
stopped by the addition of PMSF (final 
concentration 2 mM) and PrP analyzed by 
Western blotting using the polyclonal anti-PrP 
antibody A7. Aβ in conditioned medium of 
CHO-7PA2 cells or stably transfected SH-SY5Y 
cells were analyzed by immunoprecipitation 
with the polyclonal antibody 3552 followed by 
Western blotting using the monoclonal antibody 
2D8. To block Aβ generation, CHO-7PA2 cells 
were treated for 24 h with DAPT before 
immunoprecipitation. To interfere with PrPSc-
induced toxicity, transfected cells were 
pretreated for 1 h with the monoclonal anti-PrP 
antibody 3F4 (1 µg/ml) before co-culture. The 
antibody was also present during co-cultivation. 
For quantification of Hsp72, total lysates were 
analyzed by Western blotting using the 
monoclonal anti-Hsp72 antibody C92. 
Chemiluminescence was determined using a 
Fujifilm LAS-4000 ChemiDot imager and the 
Multi Gauge V3.0 software, and normalized to 
β-actin. Values of CHO-7PA2 cells or SH-SY5Y 
cells overexpressing wild type APP were 
compared to either CHO cells or mock-
transfected SH-SY5Y cells subjected to the same 
heat shock. Quantifications were based on at 
least three independent experiments. 
Exosome isolation 
Conditioned media of ScN2a or N2a cells were 
centrifuged for 10 min at 3,000xg and 
ultracentrifuged for 30 min at 10,000xg and for 
1 h at 100,000xg as described earlier (Fevrier et 
al., PNAS, 2003). Pellets were resuspended in 
cold detergent buffer A (0.5% Triton X-100, 
0.5% sodium deoxycholate in PBS) and digested 
with Proteinase K for 30 min at 37°C (final 
concentration 10 µg/ml). Reaction was stopped 
by the addition of PMSF (final concentration 2 
mM) and PrP analyzed by Western blotting 
using the polyclonal anti-PrP antibody A7. 
Luciferase Assays 
Co-cultivated SH-SY5Y cells or SH-SY5Y cells 
cultured in 3.5 cm dishes were transiently 
transfected with firefly luciferase reporter 
plasmid (HSE-luc) and subjected to the stress 
treatment indicated. After 8 h incubation at 37°C 
cells were lysed in Reporter Lysis Buffer 
(Promega). Luciferase activity was analyzed 
luminometrically using the luciferase assay 
system (Promega) and a LB96V or Mithras LB 
940 luminometer (Berthold Technologies, Bad 
Wildbad, Germany) according to the 
manufacturer´s instruction. The measured values 
were analyzed using a WinGlow Software 
(Berthold Technologies). Quantifications were 
based on at least three independent experiments. 
Apoptosis assay and immunofluorescence 
For quantification of apoptotic cell death, SH-
SY5Y cells were fixed on glass coverslips with 
3.7% paraformaldehyde for 20 min, washed and 
permeabilized with 0.2% Triton-X 100 in PBS 
for 10 min at room temperature. Fixed cells were 
incubated with an anti-active caspase-3 antibody 
overnight at 4°C, followed by an incubation with 
the secondary antibody fluorescently labeled 
with Alexa Fluor® 555 for 1 h at room 
temperature. Cells were then mounted onto glass 
slides and examined by fluorescence microscopy 
using a Zeiss Axioscope 2 plus microscope (Carl 
Zeiss). The number of cells positive for activated 
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caspase-3 from at least 1000 transfected cells 
was determined in a blinded manner. All 
quantifications were based on at least three 
independent experiments. For 
immunofluorescence analysis of the stress-
inducible Hsp72 in N2a or ScN2a or CHO or 
CHO-7PA2 cells, cells were grown on glass 
coverslips. At day 2 (CHO/CHO-7PA2) or day 4 
(N2a/ScN2a) in culture, cells were subjected to 
the heat shock indicated, returned to 37°C and 
analyzed after an additional 8 h or 16 h, 
respectively. After incubation, cells were fixed, 
permeabilized and stained for Hsp72 using the 
monoclonal anti-Hsp72 antibody C92. Nuclei 
were stained with ToPro. Cells were examined 
by confocal fluorescence microscopy using a 
Zeiss Axiovert 200M microscope (Carl Zeiss). 
Statistical analysis 
Quantifications were based on at least three 
independent experiments. Data were shown as 
means ± S.E.. Statistical analysis was performed 
using Student’s t test. P-values are as follows: * 
p < 0.05; ** p < 0.005; *** p < 0.0005. 
 
RESULTS 
The heat shock response is impaired in cell lines 
chronically exposed to PrPSc or Aβ 
 We previously showed that the HSR in 
scrapie-infected mouse neuroblastoma (ScN2a) 
cells, which propagate proteinase K (PK)-
resistant PrPSc and infectious prions (Fig. 1A), is 
significantly impaired (33,34). The amount of 
Hsp72, which is expressed at high levels only 
after heat shock or other forms of metabolic 
stress (51), is greatly increased in uninfected 
N2a cells after a heat shock of 10 or 20 min (42 
or 44°C), while ScN2a cells do not express 
Hsp72 after being subjected to the same stress 
conditions. This phenomenon is illustrated by 
Western blotting (Fig. 1C) and indirect 
immunofluorescence (Fig. 2A, left panel). 
Prompted by these results we asked whether 
chronic exposure to another pathogenic protein 
assembly would also modulate the HSR. To 
experimentally address this possibility, we made 
use of a stably transfected Chinese hamster 
ovary cell line (CHO-7PA2) that expresses the 
familial AD mutant V717F of the human 
amyloid precursor protein APP751 and secretes 
Aβ (46) (Fig. 1B, left panel). Importantly, 
secreted Aβ from CHO-7PA2 cells is 
neurotoxic, demonstrated by its ability to 
potently inhibit long-term potentiation in vivo 
and to interfere with neuronal viability 
(48,52,53). In addition, we generated a stably 
transfected SH-SY5Y cell line expressing wild 
type human APP. Similarly to the CHO-7PA2 
cells SH-SY5Y-wtAPP cells secreted 
significantly increased levels of Aβ when 
compared to the mock transfected control (Fig. 
1B, right panel). 
To analyze the HSR, we subjected CHO-7PA2 
and SH-SY5Y-wtAPP cells to different heat 
shock conditions and analyzed expression of 
Hsp72 after the cells had been cultivated for 
another 8 h at 37°C. The Western blot (Fig. 1D, 
E) and immunofluorescence analysis (Fig. 2A, 
right panel) revealed that Aβ-overexpressing 
CHO-7PA2 and SH-SY5Y-wtAPP are able to 
mount a stress response, however, the amount of 
Hsp72 in stressed CHO-7PA2 and SH-SY5Y-
wtAPP was lower when compared to CHO or 
mock transfected SH-SY5Y cells, respectively, 
subjected to the same stress conditions. These 
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differences were significant under all stress 
conditions tested for the SH-SY5Y cell lines 
(Fig. 1E), while after more severe stress (42°C 
or 44°C for 20 min) Hsp72 levels were 
comparable in CHO and CHO-7PA2 cells (Fig. 
1D). Ectopic expression of a mutant of the heat 
shock transcription factor 1 (ΔHSF), which 
contains a deletion in the regulatory domain 
(Δ202-316) and is constitutively active (38), 
induced the upregulation of Hsp72 in both 
ScN2a and CHO-7PA2 cells (Fig. 2B). These 
findings suggest that the impaired Hsp72 
expression after stress is obviously caused by a 
deregulated HSF1 activation/inactivation 
pathway and not by mutations in the promoter 
regions of stress-regulated genes (34). These 
results demonstrate that cells chronically 
exposed to Aβ or PrPSc have a higher threshold 
to mount a HSR. 
 
Acute exposure of cells to PrPSc lowers the 
threshold for a heat shock response 
 ScN2a cells had been established from a 
population of cells acutely infected with prions. 
Thus, it might well be that an impaired stress 
response was a selection advantage to counteract 
adverse effects of PrPSc on cell viability. We 
therefore wanted to analyze possible acute 
effects of PrPSc on the HSR by employing a 
novel cell culture assay, which is based on the 
co-culture of SH-SY5Y cells with N2a or ScN2a 
cells (47,48). In this context it is important to 
note that scrapie-infected cells release PrPSc and 
infectious prions into the extracellular 
environment (Fig. 1A, right panel) (54,55). Our 
experimental set-up allows us to study the HSR 
in SH-SY5Y cells after transient exposure to 
PrPSc present in the cell culture medium (Fig. 
3A). To assess the HSR in a quantitative 
manner, we used a reporter gene construct 
(HSE-luc) expressing firefly luciferase under the 
control of the highly heat-inducible promotor of 
the human Hsp70B gene (36). After a brief heat 
shock, transcription of the luciferase gene is 
induced and luciferase activity can be 
determined luminometrically (Fig. 3B). First, we 
examined whether PrPSc released by ScN2a cells 
would induce an HSR in co-cultured SH-SY5Y 
cells. Luciferase activities in SH-SY5Y cells co-
cultured with ScN2a cells for 24 h were 
comparable to those in cells co-cultured with 
N2a cells, indicating that acute exposure to PrPSc 
did apparently not induce the HSR (Fig. 3C). 
 Next we tested whether acute exposure 
to PrPSc modulates the HSR. To this end, we co-
cultured HSE-luc-expressing SH-SY5Y cells 
with ScN2a cells and then subjected them to a 
brief heat shock (Fig. 3D). SH-SY5Y cells co-
cultured with ScN2a cells showed significantly 
higher luciferase activities after a heat shock 
than cells co-cultured with N2a cells. For 
example, a 20 min heat shock at 42°C led to a 8-
fold induction of luciferase in SH-SY5Y cells 
co-cultured with N2a cells, whereas the same 
heat shock condition led to a 18.5-fold induction 
in cells pre-exposed to PrPSc (Fig. 3D). Of note, 
there was no increase in cell death of co-cultured 
SH-SY5Y cells under the heat shock conditions 
applied (Fig. 3E). 
 
Induction of the HSR or increased expression of 
Hsp72 or clusterin protects against PrPSc- or 
Aβ-induced toxicity 
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 To address the possibility that an 
induction of the HSR can protect cells from the 
toxic activity of PrPSc or Aβ, we employed a 
previously established cell culture model 
(47,48). As illustrated in Fig. 4A (left panel), 
PrPSc induces cell death in co-cultured SH-
SY5Y cells expressing the cellular prion protein 
(PrPC). Similarly, expression of PrPC sensitizes 
cells to the toxic effects of Aβ (Fig. 4B). 
Toxicity of PrPSc could be suppressed by 
performing the co-culture in the presence of the 
monoclonal anti-PrP antibody 3F4 (Fig. 4A, 
right panel). Likewise, co-cultivation with CHO-
7PA2 cells pre-treated with the γ-secretase 
inhibitor DAPT did not induce apoptotic cell 
death in PrPC-expressing SH-SY5Y cells, 
indicating that the toxic effect of CHO-7PA2 
cells was dependent on the generation of Aβ 
(48). 
To induce the HSR without a stress treatment, 
we expressed the constitutively active ΔHSF 
mutant, which increases expression of many heat 
shock proteins, for example of Hsp72 (Fig. 2B). 
SH-SY5Y cells transiently co-transfected with 
PrPC and ΔHSF or GFP as a control were co-
cultured with ScN2a or CHO-7PA2 cells, and 
apoptotic cell death was analyzed after 16 h of 
co-culturing. ScN2a or CHO-7PA2 cells induced 
cell death in co-cultured SH-SY5Y cells 
expressing PrPC and GFP, while the co-
expression of ΔHSF protected the cells from 
PrPSc- or Aβ-induced cell death (Fig. 4C). In a 
next step we tested whether it is sufficient to 
express individual chaperones to block PrPSc- or 
Aβ-induced toxicity. To analyze chaperones 
located in different cellular compartments, we 
chose Hsp72, a cytoplasmic chaperone, and 
clusterin, an extracellular chaperone that has 
recently been genetically associated with AD 
(56,57). Indeed, expression of either Hsp72 or 
clusterin was sufficient to inhibit PrPSc- or Aβ-
induced cell death (Fig. 4D and Fig. 5). 
 
Hsp72 and ΔHSF but not clusterin protect 
against a neurotoxic PrP mutant 
 Several PrP mutants can induce neuronal 
cell death in the absence of infectious prion 
propagation (rev. in (8)). PrPC can acquire a 
neurotoxic potential by deleting the internal 
hydrophobic domain (HD) (58,59). Similar to 
PrPC, PrPΔHD is glycosylated with complex 
sugars and linked to the outer leaflet of the 
plasma membrane via a GPI anchor (35). To 
assess whether an activated HSR and the 
expression of chaperones can also interfere with 
the toxic effects of a pathogenic PrP mutant 
located at the plasma membrane, we used a cell 
culture model previously established in our 
group (47,60). Upon ectopic expression of 
PrPΔHD, apoptotic cell death is induced in SH-
SY5Y cells. The toxic effects of PrPΔHD are 
abrogated by co-expression of PrPC (Fig. 6A). 
This activity of PrPC has been conclusively 
documented in various transgenic mouse models 
and cultured cells, however, the underlying 
mechanisms are elusive (47,58-63). To test a 
possible protective effect of an activated HSR or 
of individual chaperones, we co-expressed 
PrPΔHD with ΔHSF, or Hsp72, or clusterin. 
Indeed, co-expression of either ΔHSF or Hsp72 
protected cells against PrPΔHD-induced toxicity 
(Fig. 6B, C). In contrast, clusterin, which 
efficiently interfered with PrPSc- or Aβ-induced 
cell death, could not prevent toxic effects 
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mediated by PrPΔHD (Fig. 6D). Importantly, 
ΔHSF or Hsp72 expression did not reduce 
PrPΔHD protein levels nor did expression of 
PrPΔHD prevent secretion of clusterin. 
 
DISCUSSION 
 Regulation of the cellular stress response 
is critical to maintain cellular homeostasis and to 
protect cells from proteotoxicity. Our results 
indicate that pathogenic oligomers made from 
different proteins deregulate the HSR, in 
particular, they can modify the threshold for the 
stress-induced expression of heat shock proteins. 
Furthermore, we present evidence that the toxic 
effects of three different neurotoxic protein 
conformers (PrPSc, Aβ and PrPΔHD) can be 
ameliorated by activating the HSR or by 
increasing the expression of individual 
chaperones. 
 
The HSR is modulated by different pathogenic 
protein assemblies: distinct effects of acute and 
chronic exposure 
 PrPSc and Aβ form pathogenic protein 
assemblies within the secretory/endosomal 
pathway and/or at the plasma membrane. Both 
protein species are released into the extracellular 
space, where they can form amyloid plaques. To 
study how chronic exposure of neuronal cells to 
these aberrantly folded proteins might modulate 
the HSR, we made use of previously established 
cell lines generating neurotoxic PrPSc or Aβ. 
ScN2a cells represent a well-characterized cell 
culture model to study pathomechanistic 
pathways linked to prion diseases. Notably, PK-
resistant PrPSc and infectious prions are released 
into the cell culture medium. Generation of Aβ 
is a physiological process, however, it was 
previously shown that Aβ secreted into the 
medium of CHO-7PA2 cells is neurotoxic, 
demonstrated by its ability to potently inhibit 
long-term potentiation in vivo and to interfere 
with neuronal viability (48,52,53). 
 Based on the finding that the HSR 
response is significantly impaired in ScN2a cells 
(33,34), we first compared the HSR of CHO to 
that of CHO-7PA2 cells by analyzing expression 
of Hsp72, the stress-inducible Hsp70 variant, 
after moderate, non-lethal heat shock conditions. 
In contrast to ScN2a cells, CHO-7PA2 cells are 
able to increase expression of Hsp72 in response 
to heat shock, however, their efficiency to mount 
a heat shock response is reduced, which is most 
evident under mild heat shock conditions. To 
exclude the possibility that the observed effect is 
specific for CHO-7PA2 cells or the mutant 
human APP expressed in this line we show an 
impaired HSR also in stably transfected SH-
SY5Y cell lines overexpressing human wild type 
APP. Similarly to what we observed in ScN2a 
cells, forced expression of a constitutively active 
mutant of HSF1 (ΔHSF) efficiently induced 
Hsp72 expression in CHO-7PA2 cells. These 
data agreed that the reduced levels of Hsp72 in 
CHO-7PA2 cells are not due to mutations in the 
promotor region of the Hsp72 gene but rather to 
a modulation of the activation/deactivation 
pathway of HSF1. Such a scenario is in line with 
our previous finding that the impaired HSR in 
ScN2a cells is caused by an accelerated 
deactivation of HSF1 after stress (34).  
 With the help of a co-culture model we 
were able to study acute effects of pathogenic 
protein conformers on the HSR. Exposure of 
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SH-SY5Y cells to PrPSc per se did not induce 
Hsp72 expression, but increased Hsp72 
expression in response to heat shock conditions. 
Mechanistically, it is conceivable that the acute 
exposure of cells to PrPSc sensitizes the HSF1 
activation pathway thereby lowering the 
threshold for efficient Hsp72 expression in 
response to additional stress. 
 HSF activation/deactivation is regulated 
in the cytoplasmic and nuclear compartment at 
multiple steps via the interaction with 
chaperones and by different posttranslational 
modifications (rev. in (64)). It is difficult to 
discriminate whether PrPSc or Aβ modulates any 
of these steps directly by interacting with any of 
the HSF1 modulators or indirectly via disruption 
of the proteostasis. Both PrPSc and Aβ  have 
been found in the cytoplasmic compartment 
where they could interact with either HSF1 or 
chaperones implicated in HSF1 regulation. On 
the other hand, it has also been shown that 
accumulation of PrPSc or Aβ disrupts the 
proteostasis network. For example, cytosolic 
PrPSc inhibits proteasomal activity (65) and Aβ 
interferes with mitochondria function (rev. in 
(66)). 
 
Activation of the HSR or expression of cytosolic 
Hsp72 protects against toxic effects of Aβ, PrPSc 
and a neurotoxic PrP mutant 
 The possibility to harness the stress 
response therapeutically have been demonstrated 
in various misfolding disease models previously 
(22,26,64,67,68). New in our study are the 
approaches to study the cells' ability to mount a 
HSR under conditions of acute and chronic 
exposure to PrPSc and Aβ and to analyze three 
different neurotoxic proteins under comparable 
experimental conditions. Moreover, we 
evaluated the protective effect of individual 
chaperones located in different cellular 
compartments. Although the exact mechanisms 
of how PrPSc, Aβ or other pathogenic protein 
conformers interfere with neuronal function are 
largely unknown, there appear to be common 
features. In particular, there is increasing 
experimental evidence that different toxic 
protein assemblies are structurally related and 
can activate similar cellular signaling pathways 
(6-10,69,70). Notably, it has been shown that the 
cellular prion protein can serve as a cell surface 
receptor to mediate toxic signaling of both PrPSc 
and Aβ (47,48,71-85). We cannot exclude the 
possibility that cytosolic chaperones directly 
interact with PrPSc or Aβ. For example, studies 
in yeast demonstrated that chaperones can 
interact with and modulate maintenance and 
propagation of prions (rev in (86-91)). Similarly, 
employing C. elegans and yeast as models of 
poly-glutamine-induced toxicity it was shown 
that cytosolic chaperones can ameliorate toxic 
effects of aberrantly folded protein conformers 
(92-96). However, it is also plausible that the 
protective activity of ΔHSF and Hsp72 
expression is based on a modulation of PrPSc- 
and Aβ-induced signaling pathways by cytosolic 
chaperones. A potential candidate for such an 
intracellular signaling molecule is the stress-
kinase JNK since Hsp72 can alleviate toxic 
effects of various stressors by suppression of 
JNK signaling (rev. in (97)). In support of such a 
scenario are data showing that a JNK inhibitor 
suppressed toxic effects of PrPSc (47). A 
different activity of Hsp72 was recently 
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described in a mouse model of severe muscular 
dystrophy. This study indicated that Hsp72 can 
slow progression of disease by interacting with 
the sarcoplasmic/endoplasmic reticulum Ca2+-
ATPase (SERCA) (98). In this context it is 
important to note that PrPC can restrict Ca2+-
influx into the cell by limiting excessive N-
Methyl-D-aspartate (NMDA) receptor activity. 
Notably, this inhibitory activity of PrPC is lost 
upon interaction with Aβ (82,84,99).  
 Interestingly, an activated HSR and 
increased Hsp72 expression also efficiently 
prevented toxic effects of the pathogenic PrP 
mutant PrPΔHD. PrPΔHD is located at the 
plasma membrane and does not form protein 
assemblies related to PrPSc or Aβ. Different 
models have been proposed to explain the toxic 
activity of PrPΔHD, including the interaction 
with a yet unidentified receptor or a channel-
forming activity of PrPΔHD (rev. in (70,100)). 
Irrespective of the exact mechanism, our results 
indicate that structurally unrelated pathogenic 
proteins can activate similar cellular pathways 
and that PrPΔHD toxicity might be related to 
that of PrPSc and Aβ. 
 
An extracellular chaperone interferes with 
PrPSc- and Aβ- induced cell death, but not with 
neurotoxic signaling of a PrP mutant 
 Our study on clusterin revealed 
interesting activities of this extracellular 
chaperone. Similarly to Hsp72, clusterin 
protected against PrPSc- and Aβ-induced 
toxicity, however it could not interfere with 
toxic effects of PrPΔHD expression. 
 A variety of activities have been 
reported for clusterin, including modulation of 
amyloid formation by interacting with 
prefibrillar structures (101), clearance of 
extracellular misfolded proteins (102) and 
sequestration of oligomeric forms of Aβ (103). 
Thus, we suggest that despite a similar 
protective activity against PrPSc- and Aβ-
induced toxicity, Hsp72 and clusterin exert 
different modes of action. While Hsp72 seems to 
modulate intracellular pathways induced by 
PrPSc or Aβ (see above), clusterin obviously 
interferes with PrPSc- and Aβ-induced toxicity 
by a direct interaction with the toxic protein 
assemblies, most likely in the extracellular 
compartment. As a consequence, PrPSc or Aβ no 
longer interacts with PrPC at the plasma 
membrane, which in our cell culture model is the 
major cell surface receptor of PrPSc- or Aβ-
induced toxicity. The failure of clusterin to 
interfere with PrPΔHD-induced toxicity 
indirectly supports such a mode of action, since 
PrPΔHD-mediated toxicity seems not to be 
linked to the formation of β-sheet rich protein 
assemblies (rev. in (70,100)).  
 
 Our findings emphasize complex 
interrelations between the HSR and neurotoxic 
proteins. For example, toxic oligomers can both 
sensitize and desensitize the HSR in a time-
dependent manner. As a consequence it might be 
beneficial to interfere with the HSR at an early 
phase of the disease, whereas HSR stimulation is 
a possible strategy at later time points. Indeed, 
the protective effect of Hsp72 and clusterin 
supports the concept to use forced expression of 
individual chaperones or pharmacological 
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induction of the HSR to delay progression of 
neurodegenerative disease. In addition, a 
combination of chaperones promises additive or 
synergistic effects since different chaperones can 
target distinct steps in neurotoxic signaling 
pathways. 
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FIGURE LEGENDS 
Figure 1. Impaired heat shock response in cell lines chronically exposed to PrPSc or Aβ 
(A) Chronically scrapie-infected N2a cells (ScN2a) are characterized by the formation of Proteinase 
K (PK)-resistant scrapie prion protein (PrPSc). Total cell lysates and isolated exosomes prepared from 
N2a or ScN2a cells were treated with PK or left untreated and then analyzed by Western blotting 
using the polyclonal anti-PrP antibody A7. (B) Stably transfected CHO cells (CHO-7PA2) or SH-
SY5Y cells generate amyloid beta (Aβ). Aβ present in conditioned medium of CHO or CHO-7PA2 
cells and stably transfected SH-SY5Y cells was analyzed by immunoprecipitation with the polyclonal 
antibody 3552 followed by Western blotting using the monoclonal antibody 2D8. To block Aβ 
generation, CHO-7PA2 cells were treated for 24 h with DAPT before immunoprecipitation. (C-E) 
ScN2a, CHO-7PA2 and stably transfected SH-SY5Y cells exhibit an impaired heat shock response. 
(C) N2a and ScN2a cells were subjected to heat shock conditions as indicated. The stress-inducible 
heat shock protein Hsp72 was analyzed by Western blotting using the monoclonal anti-Hsp72 
antibody C92. (D) CHO and CHO-7PA2 cells were subjected to heat shock conditions as indicated. 
The stress-inducible heat shock protein Hsp72 was analyzed by Western blotting using the 
monoclonal anti-Hsp72 antibody C92. Band intensities of the Hsp72 signals from CHO and CHO-
7PA2 cells were quantified and normalized to β-actin. The fold induction of Hsp72 in CHO-7PA2 
cells in response to various stresses, relative to CHO cells is shown in the right panel. (E) Mock- and 
wild type APP-transfected SH-SY5Y cells were subjected to heat shock conditions as indicated. The 
stress-inducible heat shock protein Hsp72 was analyzed as described under Fig. 1D. The relative 
amounts of Hsp72 are represented as the mean ± S.E. of three to four independent experiments. * p < 
0,05. 
 
Figure 2. Cells chronically exposed to PrPSc or Aβ exhibit a higher threshold to mount a heat 
shock response 
(A) ScN2a and CHO-7PA2 cells have an impaired heat shock response. N2a, ScN2a, CHO and CHO-
7PA2 cells were subjected to the heat shock conditions as indicated. Hsp72 was analyzed by indirect 
immunofluorescence using the monoclonal anti-Hsp72 antibody C92. (B) Expression of a 
constitutively active mutant of the heat shock transcription factor 1 (∆HSF) induces expression of 
Hsp72 in both ScN2a and CHO-7PA2 cells. N2a, ScN2a, CHO and CHO-7PA2 cells were transiently 
transfected with wild type HSF (wtHSF) or the constitutively active ΔHSF mutant. 24 h after 
transfection expression of Hsp72 was analyzed by indirect immunofluorescence as described under 
Fig. 2A. Nuclei were stained with ToPro. Scale bars 10 µm. 
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Figure 3. Acute exposure to PrPSc lowers the threshold for a heat shock response 
(A) Schematic model of the co-culture assay. SH-SY5Y cells were plated on glass coverslips. 2 h 
after transfection, coverslips were transferred into dishes containing a 90% confluent layer of either 
ScN2a or N2a cells. After 24 h of co-culture, the coverslips were removed and the SH-SY5Y cells 
analyzed. Either luciferase activity was determined in cell lysates (B, C, D), or SH-SY5Y cells were 
fixed, permeabilized and stained for active caspase-3 to assess apoptotic cell death (E). All 
quantifications were based on at least three independent experiments. (B) Heat shock induces 
expression of luciferase. SH-SY5Y cells were transiently transfected with a reporter gene construct 
(HSE-luc) expressing firefly luciferase under the control of the highly heat-inducible promotor of the 
human Hsp70B gene. 18 h after transfection cells were subjected to a heat shock (42°C) for the time 
indicated, or held at 37°C. After additional 8 h at 37°C luciferase activity in total cell lysates was 
determined luminometrically and plotted as fold induction relative to cells held at 37°C. (C) Acute 
exposure to PrPSc does not induce a heat shock response. SH-SY5Y cells transiently transfected with 
HSE-luc were co-cultured with ScN2a or N2a cells for 24 h at 37°C and then luciferase activity was 
analyzed; fold induction relative to cells co-cultured with N2a cells at 37°C is plotted. (D) Acute 
exposure to PrPSc lowers the threshold for a stress response. SH-SY5Y cells transiently transfected 
with HSE-luc were co-cultured with ScN2a or N2a cells for 16 h at 37°C. Cells were subjected to a 
heat shock (42°C) for the time indicated, or held at 37°C. After additional 8 h at 37°C luciferase 
activity was analyzed as described above. The fold induction relative to cells co-cultured with N2a 
cells at 37°C is plotted. (E) Apoptotic cell death is not increased by the heat shock conditions tested. 
SH-SY5Y cells were co-cultured with ScN2a or N2a cells and heat shocked as described under (D). 
For quantification of apoptotic cell death, SH-SY5Y cells were fixed, permeabilized and stained for 
active caspase-3. n.s. non significant; * p < 0,05; ** p < 0,005; *** p < 0,0005. 
 
Figure 4. Induction of the heat shock response or increased expression of Hsp72 protects against 
PrPSc- and Aβ-induced toxicity 
(A) Scrapie prions induce apoptosis in SH-SY5Y cells expressing PrPC. SH-SY5Y cells expressing 
the cellular prion protein (PrPC) were co-cultured with ScN2a or N2a cells in the presence or absence 
of the monoclonal anti-PrP antibody 3F4. (B) Aβ secreted by stably transfected cells is toxic to cells 
expressing PrPC. SH-SY5Y cells expressing PrPC were co-cultured with the indicated cell lines. (C) 
Expression of a constitutively active HSF1 mutant (∆HSF) protects against PrPSc- and Aβ-induced 
toxicity. SH-SY5Y cells co-expressing PrPC and ∆HSF were co-cultivated with the indicated cell 
lines. (D) Expression of a Hsp70 variant protects against PrPSc- and Aβ-induced toxicity. SH-SY5Y 
cells co-expressing PrPC and Hsp72 were co-cultivated with the indicated cell lines. In (A-D) after 16 
h of co-culture, apoptotic cell death in SH-SY5Y cells was determined as described in Experimental 
Procedures. Expression of PrP and Hsp72 were analyzed by Western blotting using the monoclonal 
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anti-PrP antibody 3F4 or the monoclonal anti-Hsp72 antibody C92, respectively. n.s. non significant; 
* p < 0,05; ** p < 0,005; *** p < 0,0005. 
 
Figure 5. Expression of the extracellular chaperone clusterin protects against PrPSc- and Aβ-
induced toxicity 
Expression of the extracellular chaperone clusterin prevents PrPSc- and Aβ-induced toxicity. SH-
SY5Y cells co-expressing PrPC and clusterin were co-cultivated with the indicated cell lines. After 16 
h of co-culture, apoptotic cell death in SH-SY5Y cells was determined as described in Experimental 
Procedures. Expression of PrP was analyzed by Western blotting using the monoclonal anti-PrP 
antibody 3F4. Secretion of clusterin in conditioned media was determined by TCA-precipitation 
followed by Western blotting using the monoclonal anti-clusterin antibody 41D. n.s. non significant; 
** p < 0,005; *** p < 0,0005. 
 
Figure 6. Hsp72 and ΔHSF but not clusterin protect against a neurotoxic PrP mutant 
(A) Expression of PrPC protects against PrP∆HD-induced toxicity. (B, C) Hsp72 or ΔHSF interferes 
with PrPΔHD-induced toxicity. (D) The extracellular chaperone clusterin does not prevent toxic 
effects of PrPΔHD. In (A-D) apoptotic cell death in SH-SY5Y cells expressing the indicated proteins 
was determined as described in Experimental Procedures. Expression of PrP and PrPΔHD or Hsp72 
was analyzed by Western blotting using the monoclonal anti-PrP antibody 3F4 or the monoclonal 
anti-Hsp72 antibody C92. Presence of clusterin in conditioned media was determined by TCA-
precipitation followed by Western blotting using the monoclonal anti-clusterin antibody 41D. n.s. non 
significant; ** p < 0,005; *** p < 0,0005. 
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